Aquilo Capital Management as of Dec. 31, 2018
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 14 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 52.1 | $108M | 1.5M | 71.75 | |
| Merus N V (MRUS) | 10.0 | $21M | 1.5M | 14.00 | |
| Arrowhead Pharmaceuticals (ARWR) | 6.4 | $13M | 1.1M | 12.42 | |
| Uniqure Nv (QURE) | 5.7 | $12M | 409k | 28.82 | |
| Synlogic | 4.5 | $9.4M | 1.3M | 7.01 | |
| Fate Therapeutics (FATE) | 4.3 | $8.9M | 697k | 12.83 | |
| Cytomx Therapeutics (CTMX) | 3.8 | $7.9M | 525k | 15.10 | |
| Spero Therapeutics (SPRO) | 3.1 | $6.3M | 1.0M | 6.15 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $6.0M | 952k | 6.31 | |
| Argenx Se (ARGX) | 2.1 | $4.4M | 46k | 96.08 | |
| Loxo Oncology | 1.7 | $3.5M | 25k | 140.08 | |
| Galapagos Nv- (GLPG) | 1.6 | $3.3M | 36k | 91.73 | |
| Pieris Pharmaceuticals (PIRS) | 1.6 | $3.2M | 1.2M | 2.66 | |
| Morphosys (MOR) | 0.1 | $298k | 12k | 25.28 |
